GSK's HIV unit strikes China supply deal on Tivicay; FDA to probe safety of kids' cough syrups;

@FiercePharma: California strikes down exemptions to vaccination requirements for schoolchildren. FierceVaccines story | Follow @FiercePharma

@EricPFierce: Don't miss our July 8 Twitter chat on sustained release with BASF expert Thorsten Cech. Details are here. | Follow @EricPFierce

@CarlyHFierce: Boehringer gets respiratory boost with batch of Spiolto nods in EU. News | Follow @CarlyHFierce

> GlaxoSmithKline ($GSK) inked a manufacturing deal for its new HIV drug Tivicay in China, enabling the company to supply the med at cut-rate prices in the country. Report

> The FDA is investigating the use of codeine-containing cough syrups in children under 18, after European regulators in April advised against their use in children under 12. Report

> Australian lawmakers grilled Big Pharma executives at public hearings this week, as a controversy over drugmakers' low collective tax payments has touched off a call for new rules on transfer pricing. Report

> France's Ipsen updated its outlook for 2020, saying that it now expects organic sales growth to 1.8 billion to 8 billion euros ($1.99 billion to $2.21 billion), with an operating margin of more than 26%. Release (PDF) | Report

> Greece's pharma industry trade group said drugmakers would provide a constant supply of medicines through that country's financial crisis. Report

Medical Device News

@FierceMedDev: Langer Lab company gets $5M in funding for drug-delivery device. FierceDrugDelivery story | Follow @FierceMedDev

@VarunSaxena2: Cynapsus' sublingual Parkinson's med for 'off' episodes progresses to PhIII. FierceDrugDelivery report | Follow @VarunSaxena2

@EmilyWFierce: ICYMI yesterday: Analysts: Roche sale of diabetes diagnostics unit could be a long time coming. Article | Follow @EmilyWFierce

> GlySure gets CE mark for first continuous, intravascular glucose monitor for hospital use. More

> Novartis launches navigation app for visually disabled on Apple Watch. Story

Biotech News

@FierceBiotech: ICYMI yesterday: Baxalta sets sail with blockbuster ambitions for its growing pipeline. Article | Follow @FierceBiotech

@JohnCFierce: Trending yesterday: Whittled down to biotech size, AstraZeneca's antibiotics crew starts over as Entasis. Article | Follow @JohnCFierce

@DamianFierce: Join us as we search for the Amar'e Stoudemire of immuno-oncology. Listen to FierceBiotech Radio | Follow @DamianFierce

> Gilead takes a $125M FDA shortcut with its latest HIV combo. Report

> Nathalie Adda named Enanta CMO. Chutes and Ladders

> Four years after buyout, Pfizer spins Icagen ion channel platform back out. Article

Vaccines News

> Study: Flublok is more effective than traditional flu shot. Item

> Actelion pours out $33M to create vaccine startup with Max Planck Society. News

> California strikes down exemptions to vaccination requirements for schoolchildren. Story

> Sanaria raises $48.5M from Equatorial Guinea, oil and gas companies to develop malaria vaccine. Article

> Cancer vaccines field to see sizable growth, report says. More

CRO News

> Quintiles and Quest unveil their clinical trials joint venture. Item

> GVK inks another R&D deal as it moves on from data scandal. Story

> Covance joins trial site group to speed up R&D. News

> PPD strings together a site network for pediatric trials. Article

> BioClinica expands in Europe with a focus on imaging. Report

Pharma Manufacturing News

> Sanofi to improve environmental impact of its manufacturing plants. Item

> Lonza expands New Hampshire plant to make Alexion products. News

> FDA warning letter lays out cross-contamination issues at Canada plant. Story

> Listen up, eardrop makers: FDA says get products approved or face prosecution. Article

> Biogen embarks on major manufacturing expansion. News

Pharma Asia News

> Stormy Australia hearings on transfer pricing by drug firms invoke Sergeant Schultz. Report

> China's Universal prices IPO at $447M as HKEx shows attraction to healthcare. Article

> India's Marksans Pharma buys U.S.-based Time-Cap, a trend in the making? More

> Australia's Prana Biotech touts Imagine PBT2 safety trial outcome in comeback bid. Story

> GSK's ViiV unit to work with China's Desano to make API of Tivicay for access use. Item

And Finally ... President Obama visited Nashville, TN, to push an expansion of the state Medicaid program under Obamacare; lawmakers voted against such an expansion in February. Report

Suggested Articles

Which rollouts might suffer most? Those that treat chronic diseases, require doctors to administer them or face current competition, analysts say.

Novartis and Incyte will put their blockbuster JAK inhibitor into phase 3 clinical trials as a possible treatment for COVID-19, the drugmakers said.

The Cannes Lions canceled its advertising creativity conference for 2020 after media reports that many large ad agencies planned to opt out.